Features of eosinophilic esophagitis (EoE) and gastroesophageal refl ux disease (GERD) overlap. We aimed to determine whether staining for tissue biomarkers would differentiate EoE from GERD, suggesting utility for diagnosis of EoE.
INTRODUCTION
Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease characterized by symptoms of esophageal dysfunction and a marked esophageal epithelial eosinophilic infi ltrate, in the absence of other potential causes of esophageal eosinophilia ( 1, 2 ) . Th e clinical and histological features of EoE are not specifi c ( 1 ) , and may overlap substantially with features of gastroesophageal refl ux disease (GERD) ( 1, 3, 4 ) . Symptoms such as dysphagia and heartburn are common in both conditions ( 1,2,5 -9 ) , and esophageal eosinophilia, presumably the pathological hallmark of EoE, is commonly seen on esophageal biopsies in GERD as well ( 10 -12 ) . Th erefore, it is oft en a major clinical challenge to diff erentiate EoE and GERD.
Use of tissue biomarkers of eosinophil activation or infl ammation may represent a more effi cient and pathophysiologically based means for diagnosis of EoE and distinguishing it from GERD ( 13, 14 ) . Th e pathogenesis of EoE is felt to involve a Th 2 response to allergen exposure in which esophageal epithelial cells are stimulated to produce eotaxin-3, which in turn leads to eosinophil activation and release of intracellular granules, including major basic protein (MBP) ( 15 -17 ) . Other allergic proinfl ammatory mediators, including enzymes in the arachidonic acid pathway such as leukotriene A4 hydrolase (LTA4H) and leukotriene C4 synthase (LTC4S) that metabolize leukotriene precursors, may also be involved ( 18, 19 ) . While MBP and other eosinophil granule proteins have been shown to be more commonly found in EoE ( 20 -26 ) , transcription of eotaxin-3 is highly upregulated in EoE ( 27 -31 ) , and there is diff erential gene expression of LTA4H and LTC4S ( 27 ) , the diagnostic utility of these factors has not been established in EoE.
Th e aims of this study were to determine whether staining for MBP, eotaxin-3, LTA4H, and LTC4S in the esophageal epithelium diff erentiates EoE from GERD, and to assess the utility of these assays for diagnosis of EoE. We hypothesized that patients with EoE would have a greater number of cells staining for all of the selected tissue biomarkers, and that increasing numbers of positively staining cells would correctly predict EoE case status.
METHODS

Study design and patients
We conducted a case -control study of subjects in the University of North Carolina (UNC) EoE Clinicopathological database from 2000 to 2007. Details of the development of this database and selected patient characteristics have been described previously ( 7, 14, 32 ) .
Cases were patients of any age who had a new diagnosis of EoE as defi ned by the 2007 consensus guidelines ( 2 ) . Because the majority of the cases were evaluated before the publication of the guidelines, only those patients explicitly meeting all of the diagnostic criteria when applied retrospectively were included in this study. Specifi cally, cases were required to have at least one typical symptom of esophageal dysfunction (e.g., dysphagia, food impaction, heartburn, or feeding intolerance); at least 15 eosinophils per high-power fi eld (eos per h.p.f.) on esophageal biopsy; and had other causes of esophageal eosinophilia, including refl ux disease, excluded. GERD was excluded by documenting persistent esophageal eosinophilia and symptoms despite high-dose acid suppression at the time of biopsy ( n = 32), by documenting persistent esophageal eosinophilia despite prior symptoms refractory to high-dose acid suppression ( n = 15), or with negative pH monitoring ( n = 4). Of note, these cases have previously been extensively characterized with confi rmation of the diagnosis of EoE ( 9, 14 ) .
Controls were GERD patients of any age who underwent esophagogastroduodenoscopy and biopsy during the same time frame as the cases. GERD patients were defi ned by having at least one typical symptom, including heartburn, regurgitation, pain, or, in children, failure to thrive, which responded to antisecretory therapy with either a proton pump inhibitor or an H 2 receptor blocker. In addition, infl ammation, including at least 1 eos per h.p.f., was required on biopsy, and other competing causes of the presentation were excluded by the clinical evaluation. We required some degree of eosinophilia in our GERD control population to generate a clinically ambiguous group in whom EoE might be misdiagnosed, and where the diagnostic challenge to the clinician was present. Th is group was felt to have the most potential to benefi t from an assay diff erentiating GERD from EoE.
Clinical data were extracted from the electronic medical record and endoscopy reports. Factors of interest included: demographics (age at diagnosis, gender, race); symptoms; coexisting atopic disease (allergic rhinitis or sinusitis, asthma, or documented food allergy demonstrated by either symptomatic evidence of allergy with reintroduction of a food or by testing directed by an allergist); and endoscopic fi ndings (rings, linear furrows, white plaques or exudates, erosive esophagitis, and hiatal hernia).
Histology and immunohistochemistry
For histological assessment, archived pathology slides were re-reviewed by the study pathologists to determine eosinophil counts using a previously validated protocol ( 33 ) . To summarize, slides were masked as to case and control status, and the maximum eosinophil density (eosinophils per mm 2 (eos per mm 2 )) was determined aft er examination of fi ve microscopy fi elds. For purposes of comparison to previous studies, eosinophil density was then converted to eos per h.p.f. for an assumed h.p.f. size of 0.24 mm 2 , the size of an average fi eld as reported in the literature ( 7 ) .
For immunohistochemistry (IHC), formalin-fi xed paraffi nembedded tissue blocks were masked to case and control status, sectioned (5 μ m thick), and randomly sorted. Using a highvolume automated system (Dako Autostainer; Dako, Carpinteria, CA), IHC was performed according to the following protocol. Slides were deparaffi nized with xylene, steam-treated for antigen retrieval (Target Retrieval Solution; Dako), incubated with the primary antibodies of interest, incubated with a peroxidase-labeled anti-mouse polymer secondary antibody (Envision; Dako), stained with a diaminobenzidine chromogen (Innovex Biosciences, Richmond, CA), and then counterstained with hematoxylin. Th e primary antibodies included: anti-MBP (mouse, clone BMK 13, 1:40 dilution; AbD Serotec, Kidlington, UK and Raleigh, NC); anti-eotaxin-3 (mouse, no. 500-P156G, 1:50 dilution; PeproTech, Rocky Hill, NJ, USA), anti-LTA4H (rabbit, no. 160250, 1:300 dilution; Cayman Chemical, Ann Arbor, MI); and anti-LTC4S (rabbit, no. 20108, 1:200 dilution; Santa Cruz Biotechnology, Santa Cruz, CA). Lung, skin, and esophageal tissue were used as controls, as per the manufacturer ' s recommendations. Positive control slides were incubated with primary antibody while only antibody diluent (Dako) was added to the negative control slides.
In a protocol that mirrored the one used for the eosinophil counts, the IHC glass slides were scanned and converted to digital slides, and viewed with Aperio ImageScope (Aperio Technologies, Vista, CA) ( 33 ) . Th e maximum density of cells that stained positive for each antibody of interest in the esophageal epithelial layer was quantifi ed (cells per mm 2 ) in fi ve microscopy fi elds using the Aperio Positive Pixel Count Algorithm (version 9.1; Aperio Technologies) ( 32 ) .
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Statistical analysis
Summary statistics were used to characterize the cases and controls. Bivariate analysis was performed with χ 2 for categorical variables, and t -tests or Wilcoxon ' s rank-sum tests for continuous variables as appropriate. Correlations between eosinophil counts and positively staining cells for each of the four antibodies were calculated by Pearson ' s ρ ( R ). Receiver operating characteristic (ROC) curves were constructed using EoE case status as defi ned by the consensus diagnostic guidelines as the gold standard. Th e area under the curve (AUC) was calculated and compared for seven diff erent models predicting EoE case status: MBP alone; eotaxin-3 alone; LTA4H alone; LTC4S alone; eosinophil count alone; a combined model containing MBP and eotaxin-3; and a combined model containing MBP, eotaxin-3, and the eosinophil count.
To assess possible confounding and misclassifi cation of controls, we performed two pre-planned sensitivity analyses. For the fi rst, we limited the control group to only those with erosive esophagitis noted on endoscopy to provide a comparison group with documented pathological acid exposure. For the second, we limited the control group to those with ≥ 15 eos per h.p.f. on esophageal biopsy. Th is focused the analysis on the GERD patients with the highest levels of esophageal eosinophilia in whom the clinical diagnosis of EoE would be most diffi cult. We also compared this GERD sub-population to the EoE cases with fewer < 100 eos per h.p.f. to further examine cases that might be clinically ambiguous. For these comparisons, we repeated the bivariate and ROC analyses. In addition to these sensitivity analyses, we also repeated the main analyses aft er stratifying cases and control by age (adults ≥ 18 years vs. children < 18 years), and for the subset of EoE cases without erosive esophagitis on initial endoscopy.
All analyses were performed using Stata version 9 (Statacorp, College Station, TX). Th is study was approved by the UNC Institutional Review Board.
RESULTS
Patient characteristics
A total of 51 EoE cases and 54 GERD controls were included in this study ( Table 1 ). EoE cases were younger than GERD controls (24 vs. 34 years; P = 0.01), had more dysphagia (72 vs. 31 % ; P < 0.001), and had more atopic diseases and food allergy. Although the presence of a hiatal hernia was more common in the GERD group, the other typical endoscopic fi ndings of EoE, including rings, furrows, and plaques, were more common in the EoE group. Th e maximum eosinophil count was higher in the EoE group as compared with the GERD group (143 vs. 20 eos per h.p.f.; P < 0.001), and EoE patients more commonly had eosinophil degranulation, eosinophil microabscesses, and spongiosis (94 % , 92 % , and 92 % , respectively) compared with the GERD patients (43 % , 11 % , and 43 % , respectively; P < 0.001 for all). As expected based on the control group defi nition, esophageal eosinophilia was prominent in the GERD patients, mimicking the clinical situation in which it is challenging to distinguish EoE and GERD.
MBP and eotaxin-3 staining in cases and controls
Th ere was increased MBP and eotaxin-3 staining in EoE as compared to GERD ( Figure 1a ). Th is impression was documented in the quantitative analysis ( Table 2 ) . Th e maximum MBP staining density was signifi cantly higher in the EoE group than 
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Tissue Biomarkers for Diagnosis of EoE the model, it yielded an AUC of 0.96 for diagnosis of EoE as compared with consensus guidelines as the gold standard. Using eotaxin-3 alone, the AUC was 0.87. Th e AUCs for LTA4H and LTC4S were 0.58 and 0.66, respectively. For comparison, the AUC for the eosinophil count alone was 0.89. Th e AUC for a combined model of MBP and eotaxin-3 was 0.96. When MBP, eotaxin-3, and eosinophil count were combined in one model, the AUC was 0.99. Th e AUC for MBP staining alone was signifi cantly higher than both those for eotaxin-3 alone ( P = 0.006) and the eosinophil count alone ( P = 0.03). Th e combined MBP / eotaxin-3 / eosinophil count AUC was signifi cantly higher than the AUC for the eosinophil count alone ( P = 0.007), but not for MBP staining alone ( P = 0.19; Figure 3 ). On sensitivity analysis, the same results were noted aft er limiting the control group to only those with erosive refl ux disease or to only those with an esophageal eosinophil count of ≥ 15 eos per h.p.f. (data not shown). In addition, repeating this sensitivity analysis aft er excluding cases of EoE with ≥ 100 eos per h.p.f., who might be count 36 ± 23; data not shown). In the overall study population, while MBP density and eosinophil count strongly correlated ( R = 0.81; P < 0.001), correlation with eotaxin-3 was weaker ( R = 0.25; P = 0.01). Th ese results also persisted aft er accounting for the diff erent age distribution in the case and control groups.
LTA4H and LTC4S staining in cases and controls
In contrast, there were few appreciable qualitative diff erences in LTA4H and LTC4S staining between the EoE and GERD groups ( Figure 1b ). On quantitative analysis ( ; P = 0.001). When plotted, the case and controls had substantial overlap in the staining distributions of both of these markers ( Figure 2b ). Th ere was poor to weak correlation between the eosinophil count and LTA4H ( R = − 0.02; P = 0.85) and LTC4S ( R = − 0.24; P = 0.02). Th ese results were also unchanged aft er sensitivity analysis (data not shown).
Tissue biomarkers for diagnosis of EoE
To investigate the utility of each of the four tissue biomarkers for diagnosis of EoE, ROC curves were constructed ( Figure 3 ). When MBP staining alone was used as the only parameter in Receiver operating characteristic (ROC) curves for diagnosis of eosinophilic esophagitis (EoE) using consensus guidelines as the gold standard. The x axis is 1-specifi city and the y axis is sensitivity. The dotted gray line represents a test that performs no better than chance, which by defi nition has an area under the curve (AUC) of 0.5. A perfect test would have a curve with a line parallel to the y axis (specifi city of 100 % ) and a line parallel to the x axis (sensitivity of 100 % ), with an AUC of 1.0. In this fi gure, the AUC was calculated for seven conditions: leukotriene A4 hydrolase (LTA4H) staining alone; leukotriene C4 synthase (LTC4S) staining alone; eotaxin-3 (eot) staining alone; major basic protein (MBP) staining alone; the eosinophil (eos) count alone; the combination of MBP and eotaxin-3; and the combination of MBP, eotaxin-3, and the eosinophil count. Sensitivity and specifi city are typically maximized in the upper left-most area of each ROC curve. For example, for the MBP staining-alone ROC curve (dotted blue line), the maximum sensitivity and specifi city are 90 % and 91 % , respectively, as noted with a black dot. For the ROC curve for the combination of MBP and eotaxin-3 (dotted green line), the black dot represents the maximum sensitivity and specifi city of 90 % and 94 % , respectively. For the ROC curve for the combination of MBP, eotaxin-3, and the eosinophil count (solid green line), the black dot represents the maximum sensitivity and specifi city of 95 % and 94 % , respectively. For these latter two curves, sensitivity and specifi city are maximized on the curves when the MBP staining level is 300 cells per mm 2 and the eotaxin-3 staining level is 600 cells per mm less likely to present a diagnostic challenge, did not signifi cantly changes the results (data not shown). Finally, the results were also similar aft er stratifying patients by age (adult vs. child) and aft er limiting the EoE cases to those without erosive esophagitis (data not shown).
DISCUSSION
Eosinophilic esophagitis is a clinicopathological condition; the correct clinical and histological features are required to make the diagnosis, and the diagnostic guidelines emphasize the importance of excluding competing causes of esophageal eosinophilia ( 1, 2 ) . Because clinical and histological features of EoE and GERD overlap, in practical terms GERD is the most common cause of esophageal eosinophilia that must be distinguished from EoE ( 3 -12 ) . Th is diff erentiation between EoE and GERD can be challenging, but is crucial as management strategies for the two conditions are divergent ( 1, 12 ) .
Th is study examined IHC staining of tissue biomarkers such as MBP, eotaxin-3, LTA4H, and LTC4S for diagnosis of EoE by comparing EoE cases to GERD controls. Th ese biomarkers were selected specifi cally because they were felt to be pertinent to the pathophysiology of EoE and unlikely to be increased in GERD ( 15,20 -22,25,27 -31 ) . Moreover, the GERD controls were selected to have infl ammation, including prominent eosinophilia, on their esophageal biopsies to mimic the clinical situation in which it can be diffi cult to distinguish EoE from GERD. We found that there was signifi cantly higher MBP and eotaxin-3 staining in the esophageal epithelium in EoE patients compared with GERD patients, but that LTA4H and LTC4S staining was similar between the groups. Th is result held even aft er limiting the controls to those with the highest eosinophil counts. In addition, the correlation between the esophageal eosinophil count and MBP and eotaxin-3 staining was not high, suggesting that performing IHC could add diagnostic information to the eosinophil count alone. On ROC analysis, the presence of increased numbers of cells staining for MBP and eotaxin-3 was actually more predictive of EoE cases status than was the eosinophil count itself. Th is is especially remarkable when one considers that the eosinophil count is one of the components of the case defi nition of EoE. Moreover, the combination of MBP staining, eotaxin-3 staining, and the eosinophil count nearly perfectly distinguished EoE and GERD, but we acknowledge that by including the eosinophil count in the ROC analysis, the predictive power of the model could be increased as eosinophil count is also a component of the case defi nition.
Th ese results are consistent with what is known about EoE pathogenesis. In an allergen-induced Th 2 response, factors such as interleukin-13 stimulate esophageal epithelial cells to produce eotaxin-3, which in turn recruits eosinophils to the esophagus
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Tissue Biomarkers for Diagnosis of EoE crucial feature of case -control studies, we also performed preplanned sensitivity analyses. Th at MBP and eotaxin-3 remained elevated in EoE, even when the EoE patients with lower eosinophil counts were compared to GERD patients with high levels of esophageal eosinophilia, implies that the activated eosinophils in EoE can potentially be exploited to improve the diagnostic algorithm for EoE.
More generally, this study points to a novel diagnostic algorithm for EoE, which relies on the pathogenic basis of the disease, as opposed to an arbitrary cutoff number of cells per high powered fi eld. In addition to being intuitively more appealing, such an approach has other potential benefi ts. For instance, currently many patients diagnosed with EoE must undergo two diagnostic upper endoscopies -an initial exam, oft en performed for dysphagia, and a second, confi rmatory exam aft er a course of acid suppressive therapy, to re-assess eosinophil counts and to rule out proton pump inhibitor-responsive esophageal eosinophilia. An algorithm assessing pathological eosinophil activity has the potential to allow diagnosis at a single endoscopy session. While the current work cannot substantiate this approach, future studies should assess this highly clinically relevant question.
In conclusion, patients with EoE had substantially higher levels of MBP and eotaxin-3 staining in the esophageal epithelium compared with GERD patients, but there was no diff erence between groups for LTA4H and LT4CS staining. Staining with MBP and eotaxin-3 provided added diagnostic value beyond eosinophil counts alone, and MBP staining in particular had the more prominent eff ect. Utilizing tissue biomarkers such as MBP and eotaxin-3 may improve upon the current diagnostic standards by adding a measure of eosinophil activity that is physiologically important, and could add a pathogenic basis to the diagnosis of EoE.
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In contrast, the role of leukotrienes in EoE is less well established. LTA4H and LTC4S are key synthesis enzymes in the arachidonic acid pathway that metabolize precursors to leuko triene eff ectors and are diff erentially expressed in EoE ( 27 ) . Th ere have been several case series that report a clinical benefi t of leukotriene antagonist therapy in patients with EoE ( 19, 34, 35 ) , but there is debate as to whether this medication class is truly eff ective ( 36 ) . In addition, a prior study showed that cysteinyl leukotriene levels were similar in EoE patients and normal controls ( 18 ) . Our results are consistent with these latter data, as LTA4H and LTC4S staining were not helpful for diff erentiating EoE from GERD.
When interpreting the results from this study, there are several potential limitations to consider. First, this was a retrospective study conducted at a single center with a highly selected patient population. However, features of our EoE case population refl ect the typical characteristics of EoE populations reported from other centers and lend validity to the data ( 37 -42 ). Second, it is possible that there could have been misclassifi cation of cases and controls. However, because the EoE cases included in this study were extensively characterized and met consensus EoE diagnostic criteria with exclusion of GERD ( 9, 14 ) , misclassifi cation of EoE patients is unlikely. Furthermore, had misclassifi cation occurred, the bias would have been towards the null with the reported results representing an underestimation of the association between the biomarkers and the disease state. Finally, the single time point of the analysis, which was at diagnosis, limits conclusions that can be drawn about the diagnostic utility of these staining modalities in a proton pump inhibitor-na ï ve patient population. Because this was a retrospective study that utilized samples obtained before the recognition of proton pump inhibitor-responsive esophageal eosinophilia, we are unable to comment on the utility of this staining approach in that population ( 1, 43, 44 ) . Th e use of MBP and eotaxin-3 staining will need to be validated prospectively in each of these patient groups before it can be recommended for routine use, and eff orts to do so are underway.
Th e strengths of this study include a large number of wellcharacterized incident cases, masked histological re-review of esophageal biopsy specimens, and quantitative IHC analysis. Because there is ongoing controversy concerning the relationships between EoE, GERD, and esophageal eosinophilia ( 5, 45, 46 ) , and because correct study group defi nitions are a 
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